(Total Views: 85)
Posted On: 09/23/2022 6:48:20 AM
Post# of 38430

$MYNZ - Received supportive feedback from the U.S. Food and Drug Administration (FDA) on ColoAlert’s pre-submission package for its U.S. pivotal clinical trial set to commence in Q4 2022.
https://finance.yahoo.com/news/mainz-biomed-r...00420.html
https://finance.yahoo.com/news/mainz-biomed-r...00420.html

